Sciinov Insights analyses that the human microbiome market is expected to undergo a CAGR of 22.95% during the forecast period. This indicates that the market value, which was USD 599 million in 2021, would rocket up to USD 3,127.916 million by 2029. “Therapeutics” dominates the application segment of the human microbiome market owing to the increasing number of technological advancements and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Sciinov Insights Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Human Microbiome Market Scope
The human microbiome market is segmented on the basis of product, application and disease type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product
Probiotics
Prebiotics
Medical Foods
Supplements
Others
On the basis of product, the human microbiome market in is segmented into probiotics, prebiotics, medical foods, supplements and others.

Application
Therapeutics
Diagnostics
On the basis of application, the human microbiome market in is segmented into therapeutics and diagnostics.

Disease Type
Obesity
Diabetes
Autoimmune Disorder
Metabolic and Gastrointestinal Disorders
Cancer
Other Diseases
On the basis of disease type, the human microbiome market in is segmented into obesity, diabetes, autoimmune disorder, metabolic and gastrointestinal disorders, cancer and other diseases.

Human Microbiome Market Regional Analysis/Insights
The human microbiome market is analysed and market size insights and trends are provided by country, product, application and disease type as referenced above.

The countries covered in the human microbiome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.